404
+1-313-307-4176
Veno Arterial ECMO System Market Report
Veno-Arterial ECMO System Market Trends, Dynamics & Market Insights
Veno-Arterial ECMO System Market, By Product (Portable Type, Fixed Type), Application (Neonatal, Pediatric, Adult), and Region - COVID-19 Impact Analysis and Forecast to 2026. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Veno-Arterial ECMO System market. The historic years considered for the study are 2016-2019, the base year is 2020, and the forecast period is 2021-2026.
The Veno-Arterial ECMO System market is projected to grow from USD 262.3 million in 2020 to USD 326.5 million by 2026 at a CAGR of around 3.8% during the forecast period.
Wish to get a free sample? Register Here
Veno-arterial extracorporeal membrane oxygenation (ECMO) also referred to as extracorporeal life support will be defined as a type of temporary mechanical circulatory support and simultaneous extracorporeal gas exchange. It's emerged as a salvage intervention in patients with cardiogenic shock, even cardiopulmonary arrest refractory to plain therapies.
Key players operating in the Veno-Arterial ECMO System market are-
The growth of Veno-Arterial ECMO System market is primarily driven by rising incidences of pulmonary diseases and cardiac arrest. Increasing prevalence of heart related diseases due to stress and unhealthy eating habits is likely to propel the market growth at a significant rate during the review period. In addition to this, rising demand for technologically advanced veno-arterial ECMO system is likely to create lucrative opportunities for the players operating in the global market in the coming years.
By application, the veno-arterial ECMO system market has been bifurcated into neonatal, pediatric and adult. Under these, the adult segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to high product adoption rate and presence of key market players such as CytoSorbents Corporation (US). The market growth in Asia-Pacific region is expected to be driven by rising number of patients having pulmonary or cardiovascular diseases.
The covid-19 outbreak posed significant challenges on the various verticals across geographies. It impacted the growth of the veno-arterial ECMO system market negatively for a short period of time as imposition of complete lockdown and restrictions on trade affected the product supply.
Here is the list of the group of customers that the veno-arterial ECMO system market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The veno-arterial ECMO system market is expected to witness an impressive growth of 3.8% CAGR in the coming years.
Sorin Group (Italy), Medtronic plc (Ireland), MAQUET Holding B.V. & Co. KG (Germany), Terumo Corporation (Japan), Xenios AG (Germany), Nipro Corporation (Japan), MicroPort (China), CORMED Medizintechnik GmbH & Co. KG (Germany), Medos Medizintechnik AG (Germany), LivaNova, PLC (UK), CytoSorbents Corporation (US) are among the key players in the veno-arterial ECMO system market.
The veno-arterial ECMO system market size is expected to reach USD 326.5 million in the foreseeable future.
Adult segment accounted for the largest share in the veno-arterial ECMO system market in 2020.
North America is expected to grow at a significant CAGR in the veno-arterial ECMO system market during the next five years.
Veno-arterial ECMO system distributors, Veno-arterial ECMO system suppliers, Veno-arterial ECMO system manufacturers, Logistics organizations, Government bodies are the target audience in the veno-arterial ECMO system market.
WE ACCEPT
